APA (7th ed.) Citation

Y, Z., T, J., R, Z., W, T., H, Y., J, T., . . . S, Z. (2026). SZQ-3, a Novel Synthetic Chromone-Maleimide Hybrid Targeting NF-κB, Prevents Postmenopausal Osteoporosis by Modulating Mitochondrial Function in Bone Cells. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 40(8), e71749. https://doi.org/10.1096/fj.202502681RR

Chicago Style (17th ed.) Citation

Y, Zhang, et al. "SZQ-3, a Novel Synthetic Chromone-Maleimide Hybrid Targeting NF-κB, Prevents Postmenopausal Osteoporosis by Modulating Mitochondrial Function in Bone Cells." FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology 40, no. 8 (2026): e71749. https://doi.org/10.1096/fj.202502681RR.

MLA (9th ed.) Citation

Y, Zhang, et al. "SZQ-3, a Novel Synthetic Chromone-Maleimide Hybrid Targeting NF-κB, Prevents Postmenopausal Osteoporosis by Modulating Mitochondrial Function in Bone Cells." FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, vol. 40, no. 8, 2026, p. e71749, https://doi.org/10.1096/fj.202502681RR.